Lilly / VA Outcomes Group / RAND Health / Pfizer / Leapfrog Group / Unicon Research Corp. / Puget / /
Continent
America / /
Country
United States / /
Currency
USD / / /
Facility
National Cancer Institute / University of North Carolina / Bioinformatics Building / Chapel Hill / / /
IndustryTerm
hospital outpatient services / cancer treatment / care for most stages of the disease / care for patients with kidney cancer / therapies for metastatic kidney cancer / inpatient services / pharmaceutical cost / treatment of kidney cancer / treatment for metastatic disease / abdominal imaging / /
MedicalCondition
primarily small tumors / Urologic Diseases / low stage disease / advanced and metastatic disease / metastatic kidney cancer / chronic renal disease / carcinoma / small kidney tumors / metastatic disease / idney cancer / chronic kidney disease / obesity / specific renal carcinoma / tumor / small renal tumors / hypertension / common cancer / cancer / tumors / disease / T1 disease / emphysema / That year kidney cancer / renal carcinoma / kidney neoplasms / female cancer / pain / heart attack / low stage tumors / astatic kidney cancer / comorbid diseases / renal pelvis cancer / curable disease / kidney cancer / /
MedicalTreatment
open surgery / surgery / immunotherapy / surgeries / major surgery / Laparoscopic surgery / /
NaturalFeature
Chapel Hill / /
Organization
National Cancer Institute / University of North Carolina / Medicare / Division of Urology / Division of Urologic Surgery / AMERICAN UROLOGICAL ASSOCIATION / International Agency for Research / /
Person
Geoffrey F. Joyce / Matthew Wise / / /
Position
physician / surgeon / /
ProvinceOrState
Hawaii / Connecticut / New Mexico / Utah / North Carolina / Iowa / /
Urologic Diseases in America Project Kidney Cancer Eric M. Wallen,*,† Raj S. Pruthi, Geoffrey F. Joyce, Matthew Wise and the Urologic Diseases in America Project From the Division of Urology, University of North Caroli